KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bloomin' Brands (BLMN) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for Bloomin' Brands (BLMN) over the last 14 years, with Q4 2024 value amounting to $31.6 million.

  • Bloomin' Brands' Asset Writedowns and Impairment fell 833.84% to $31.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $64.3 million, marking a year-over-year increase of 9149.04%. This contributed to the annual value of $64.3 million for FY2024, which is 9149.04% up from last year.
  • Latest data reveals that Bloomin' Brands reported Asset Writedowns and Impairment of $31.6 million as of Q4 2024, which was down 833.84% from $5.6 million recorded in Q3 2024.
  • Bloomin' Brands' 5-year Asset Writedowns and Impairment high stood at $41.3 million for Q1 2020, and its period low was -$6.0 million during Q3 2023.
  • For the 5-year period, Bloomin' Brands' Asset Writedowns and Impairment averaged around $9.7 million, with its median value being $4.0 million (2021).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 303518.52% in 2021, then plummeted by 39066.28% in 2023.
  • Quarter analysis of 5 years shows Bloomin' Brands' Asset Writedowns and Impairment stood at $10.1 million in 2020, then tumbled by 52.87% to $4.8 million in 2021, then plummeted by 60.94% to $1.9 million in 2022, then surged by 1746.17% to $34.4 million in 2023, then decreased by 8.34% to $31.6 million in 2024.
  • Its Asset Writedowns and Impairment stands at $31.6 million for Q4 2024, versus $5.6 million for Q3 2024 and $16.3 million for Q2 2024.